Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Time-dependent activity of N-acetylcysteine on plasma antioxidant capacity (Studio CAPITAL)
2019-004188-35Phase 2Completed
- Sponsor
- Centro Cardiologico Monzino
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of acetylcysteine in heart failure (HF) and hypertension (HTN) (3 arms), sponsored by Centro Cardiologico Monzino. Primary endpoints: Cysteinylated albumin (Cys-HSA) levels and Plasma antioxidant capacity. Started Oct 2020; status: completed.
02
Drugs
acetylcysteine
03
Conditions
heart failure (HF)hypertension (HTN)
Beyond the preview
Go deeper on 2019-004188-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004188-35.